Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
226.36
-1.17 (-0.51%)
At close: Sep 24, 2026, 4:00 PM EDT
226.50
+0.14 (0.06%)
Pre-market: Sep 25, 2026, 4:01 AM EDT

Biogen Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Wells Fargo
Wells Fargo
Buy
Maintains
$250
BuyMaintains$250+10.44%Sep 18, 2026
HSBC
HSBC
Sell
Maintains
$165 → $175
SellMaintains$165 → $175-22.69%Sep 10, 2026
BMO Capital
BMO Capital
Hold
Maintains
n/a
HoldMaintainsn/an/aSep 9, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$225 → $245
BuyReiterates$225 → $245+8.23%Sep 3, 2026
RBC Capital
RBC Capital
Buy
Reiterates
$240 → $260
BuyReiterates$240 → $260+14.86%Aug 25, 2026
Wolfe Research
Wolfe Research
Buy
Upgrades
$300
BuyUpgrades$300+32.53%Aug 13, 2026
Barclays
Barclays
Hold
Maintains
$200
HoldMaintains$200-11.65%Aug 13, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$221 → $241
BuyMaintains$221 → $241+6.47%Aug 3, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.